Prostate-specific antigen kallikrein, non-ST elevation myocardial infarction and a new-onset atrial fibrillation in hypertensive patients

International Journal of Cardiology

Volumn 167, Issue 1, 2013, Pages 283-284

  Patanè, Salvatore ^a  

^a Cardiologia Ospedale San Vincenzo   (Italy)

Author keywords

Hypertensive patients; New onset atrial fibrillation; Non ST elevation myocardial infarction; Prostate specific antigen kallikrein

Indexed keywords

C REACTIVE PROTEIN; KALLIKREIN; PROSTATE SPECIFIC ANTIGEN;

ACUTE CORONARY SYNDROME; AGE DISTRIBUTION; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; LETTER; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING;

EID: 84878589705     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.208     Document Type: Article

References (41)

1. A. Dominguez-Rodriguez, P. Abreu Gonzalez, P. Avanzas, and I. Ferreira-González Are prostate-specific antigen levels predictors of acute coronary syndrome or atrial fibrillation? Int J Cardiol 165 3 2013 May 25 550
2. S. Patanè, and F. Marte Prostate-specific antigen levels in hypertensive patients suffering from a non-ST elevation myocardial infarction or a new-onset atrial fibrillation Int J Cardiol 158 3 2012 Jul 26 380 382
3. A. Dominguez-Rodriguez, P. Abreu-Gonzalez, P. Avanzas, C. Hernandez-Garcia, M. Carrillo-Perez Tome, and A. Lara-Padron Prostate-specific antigen kallikrein is not a marker of non-ST elevation acute coronary syndrome Int J Cardiol 149 1 2011 May 19 141 142
4. S. Patanè, and F. Marte Prostate-specific antigen kallikrein and acute myocardial infarction: where we are. Where are we going? Int J Cardiol 146 1 2011 Jan 7 e20 e22
5. S. Patanè, and F. Marte Prostate-specific antigen kallikrein: from prostate cancer to cardiovascular system Eur Heart J 30 10 May 2009 1169 1170
6. J. Koller-Strametz, M. Fritzer, and M. Gwechenberger Elevation of prostate-specific markers after cardiopulmonary resuscitation Circulation 102 3 Jul 18 2000 290 293
7. R. Berent, J. Auer, and M. Porodko Influence of cardiopulmonary resuscitation on levels of tumour markers Eur J Cancer Care (Engl) 15 3 Jul 2006 252 256
8. R.A. Mahfouz, N.K. Cortas, G. Ibrahim, S. Khalife, and R.T. Daher Variations in prostate-specific antigen free/total ratio in acute stress Scand J Clin Lab Invest 68 7 2008 624 627
9. P.G. Hagood, R.O. Parra, and J.A. Rauscher Nontraumatic evaluation of prostate specific antigen following cardiac surgery and extracorporeal cardiopulmonary bypass J Urol 152 1994 2043 2045
10. B.S. Parlaktas, E. Naseri, N. Uluocak, A.O. Elalmis, F. Erdemir, and I. Etikan Comparison of the effects of on-pump versus off-pump coronary artery bypass surgery on serum prostate-specific antigen levels Int J Urol 13 3 Mar 2006 234 237
11. N.R. Netto Júnior, M.L. Lima, M.A. Guedes, L.L. Patino, and J.B. de Oliveira Elevation of prostate specific antigen in cardiac surgery with extracorporeal cardiopulmonary circulation J Urol 159 3 Mar 1998 875 877
12. S. Guvel, R. Turkoz, and T. Egilmez Does ischemia-induced prostate damage during cardiac surgery involving cardiopulmonary bypass cause bladder outlet obstruction? Urol Int 74 4 2005 337 340
13. M. Koreny, J. Koller-Strametz, and A. Geppert Elevation of prostatic markers following cardiogenic shock Intensive Care Med 27 2 Feb 2001 447
14. M. Crook, K. Preston, and I. Lancaster Serum prostatic specific-antigen concentrations in acute myocardial infarction Clin Chem 43 9 Sep 1997 1670
15. S. Patanè, and F. Marte Paroxysmal ventricular tachycardia and paroxysmal atrial fibrillation associated with subclinical hyperthyroidism, chronic renal failure and elevation of prostate specific antigen during acute myocardial infarction Int J Cardiol 138 3 Feb 4 2010 e44 e46
16. S. Patanè, F. Marte, G. Di Bella, and G. Ciccarello Changing axis deviation and elevation of prostate-specific antigen during acute myocardial infarction Int J Cardiol 135 1 Jun 12 2009 e4 e5
17. S. Patanè, F. Marte, G. Di Bella, and G. Ciccarello Changing axis deviation, paroxysmal atrial fibrillation and elevation of prostate-specific antigen during acute myocardial infarction Int J Cardiol 137 2 Oct 2 2009 e37 e40
18. S. Patanè, F. Marte, M. Sturiale, R. Grassi, and F. Patanè Significant coronary artery disease associated with coronary artery aneurysm and elevation of prostate-specific antigen during acute myocardial infarction Int J Cardiol 141 3 Jun 11 2010 e39 e42
19. S. Patanè, F. Marte, and M. Sturiale Prostate-specific antigen kallikrein complexes and acute myocardial infarction Int J Cardiol 145 2 Nov 19 2010 227 228
20. S. Patanè Prostate-specific antigen kallikrein and the heart World J Cardiol 1 1 December 31 2009 23 25
21. S. Patanè, and F. Marte Paroxysmal atrial fibrillation during acute myocardial infarction associated with subclinical hyperthyroidism, severe three vessels coronary artery disease and elevation of prostate-specific antigen after TURP Int J Cardiol 138 2 Jan 21 2010 e28 e30
22. T. Ozcan, M. Bozlu, N. Muslu, K. Gozukara, S. Seyis, and B. Akcay Elevation of the serum total and free prostate specific antigen levels after stent implantation in patients with coronary artery disease Swiss Med Wkly 139 45-46 2009 672 675
23. S. Patanè, and F. Marte Prostate-specific antigen and acute myocardial infarction: a possible new intriguing scenario Int J Cardiol 134 3 May 29 2009 e147 e149
24. S. Patanè, F. Marte, M. Sturiale, and G. Dattilo ST-segment elevation and diminution of prostate specific antigen in a patient with coronary spasm and without significant coronary stenoses Int J Cardiol 148 2 Apr 14 2011 e31 e33
25. G. Vyssoulis, E. Karpanou, S.M. Kyvelou, C. Vlachopoulos, V. Tzamou, and C. Stefanadis Prostate-specific antigen levels are associated with arterial stiffness in essential hypertensive patients J Sex Med Aug 16 2010
26. J.G. Stone, R.K. Rolston, and M. Ueda Evidence for the novel expression of human kallikrein-related peptidase 3, prostate-specific antigen, in the brain Int J Clin Exp Pathol 2 3 2009 267 274 [Epub 2008 Oct 20]
27. A.F. Nash, and I. Melezinek The role of prostate specific antigen measurement in the detection and management of prostate cancer Endocr Relat Cancer 7 1 Mar 2000 37 51 [Review]
28. H.G. Rittenhouse, J.A. Finlay, S.D. Mikolajczyk, and A.W. Partin Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate Crit Rev Clin Lab Sci 35 1998 275 368
29. L. Jia, and G.A. Coetzee Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus Cancer Res 65 17 Sep 1 2005 8003 8008
30. H.C. Wu, J.T. Hsieh, M.E. Gleave, N.M. Brown, S. Pathak, and L.W. Chung Derivation of androgen independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells Int J Cancer 57 3 May 1 1994 406 412
31. S. Kamoshida, and Y. Tsutsumi Extraprostatic localization of prostatic acid phosphatase and prostate-specific antigen: distribution in cloacogenic glandular epithelium and sex-dependent expression in human anal gland Hum Pathol 21 11 Nov 1990 1108 1111
32. P. Henttu, and P. Vihko Steroids inversely affect the biosynthesis and secretion of human prostatic acid phosphatase and prostate-specific antigen in the LNCaP cell line J Steroid Biochem Mol Biol 41 3-8 Mar 1992 349 360
33. D.A. Wolf, P. Schulz, and F. Fittler Transcriptional regulation of prostate kallikrein-like genes by androgen Mol Endocrinol 6 5 May 1992 753 762
34. J.E. Oesterling, S.J. Jacobsen, and C.G. Chute Serum prostate specific antigen in a community based population of healthy men: establishment of age-specific reference ranges JAMA 270 7 Aug 18 1993 860 864
35. G.J. Gormley, E. Stoner, and R.C. Bruskewitz The effect of finasteride in men with benign prostatic hyperplasia N Engl J Med 327 17 Oct 22 1992 1185 1191
36. H.H. Juang, Y.F. Lin, P.L. Chang, and K.H. Tsui Cardiac glycosides decrease prostate specific antigen expression by down-regulation of prostate derived ets factor J Urol 184 5 Nov 2010 2158 2164 [Epub 2010 Sep 17]
37. S.L. Chang, L.C. Harshman, and J.C. Presti Jr. Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination Survey J Clin Oncol 28 25 Sep 1 2010 3951 3957 [Epub 2010 Aug 2]
38. A.S. Murad, L. Down, and G. Davey Smith Associations of aspirin, nonsteroidal anti-inflammatory drug and paracetamol use with PSA-detected prostate cancer: Findings from a large, population-based, case-control study (the ProtecT study) Int J Cancer 128 6 Mar 15 2011 1442 1448
39. A.M. Algotar, P.A. Thompson, and J. Ranger-Moore Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity Prostate 70 8 Jun 1 2010 883 888
40. J.H. Fowke, S.S. Motley, and J.A. Smith Jr. Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volume J Urol 181 5 May 2009 2064 2070 [Epub 2009 Mar 14]
41. D.J. Mener Prostate specific antigen reduction following statin therapy: mechanism of action and review of the literature IUBMB Life 62 8 Aug 2010 584 590